News
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...
New Delhi: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.
Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions ...
Type 5 Diabetes, has now come under the spotlight after official recognition by the International Diabetes Federation. This ...
A new study has stunned experts after researchers found that New Zealand blackcurrant extract – CurraNZ - can supercharge fat ...
Lead researcher on the study, Dr Matthew Cook, describes the study as a ‘watershed moment’ in blackcurrant research, saying: ...
A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...
Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...
Hosted on MSN7d
Lilly's oral diabetes pill shows potential for blood sugar control and weight loss in global trialis being studied for adults with type 2 diabetes who are not on any anti-diabetic medication and have been managing their ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results